胰腺癌是香港第五大癌症死亡原因，也是全球第七大癌症死亡原因。2020年，全球约有496000宗胰腺癌新确诊个案。胰腺癌是一种高度致命的癌症，全球病死率为94.0%。
适应症：Pancreatic Steatosis、Pancreatic Cyst
入组条件
纳入标准
- Age 18 or older
- Patients with at least 1 pancreatic cystic lesion presumed to be IPMN or MCN based on CT, MRI or EUS features, with a cyst size ≥ 5mm; or healthy subjects.
- Patients who are able to provide written informed consent to participate in the study and comply with the study procedures.
排除标准
- Unable to provide written informed consent
- Patients with metallic implants or other contraindications to MRI
- Patients with contraindications for endoscopy due to comorbidities
- Patients with known pancreatic cancer or prior pancreatic resection
- Patients with significant alcohol consumption, defined as alcohol intake of over 20 g daily (140 g weekly) for men and 10 g daily (70 g weekly) for women
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。